Relapsed or Refractory Systemic Light Chain Amyloidosis
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Systemic Light Chain Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis (NCT01659658) | Millennium Pharmaceuticals, Inc. | 2012-12-26 |
Track Relapsed or Refractory Systemic Light Chain Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.